Arab Finance: Ibnsina Pharma (ISPH) will distribute cash dividends worth EGP 0.1003433617 per share to shareholders for the full year 2021 as of June 8^th, according to a statement filed to the Egyptian Exchange (EGX) on May 22^nd.

The eligibility in dividends payment will be to shareholders on a record date of June 5^th.

It is worth noting that Ibnsina Pharma reported a 17.8% year-on-year (YoY) increase in consolidated net profit attributable to the parent company for the first quarter (Q1) of 2022, recording EGP 59.38 million, as compared to a profit of EGP 50.37 million in Q1 2021.

The company also announced the acquisition of El Shorouk Hospital in a consideration of EGP 430 million, including only EGP 200 million in cash and the rest sum as debt settlement.

Established in 2001, Ibnsina Pharma is the second-largest pharmaceutical distributor in Egypt, distributing products from over 350 global and local companies to more than 46,000 customers of pharmacies, hospitals, wholesalers, and healthcare institutions.